ARTICLE | Clinical News
Tesmilifene regulatory update
May 22, 2006 7:00 AM UTC
FDA granted Fast Track designation to tesmilifene to treat advanced breast cancer. Tesmilifene is a small molecule chemopotentiator that kills multi-drug resistant cells through its interaction with ...